These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33772927)

  • 1. Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
    Kolanska K; Dabi Y; Dechartres A; Cohen J; Ben Kraiem Y; Selleret L; Mathieu d'Argent E; Placais L; Cheloufi M; Johanet C; Rosefort A; Bornes M; Suner L; Delhommeau F; Ledée N; Chabbert Buffet N; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Am J Reprod Immunol; 2021 Aug; 86(2):e13425. PubMed ID: 33772927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
    Mekinian A; Cohen J; Alijotas-Reig J; Carbillon L; Nicaise-Roland P; Kayem G; Daraï E; Fain O; Bornes M
    Am J Reprod Immunol; 2016 Jul; 76(1):8-28. PubMed ID: 26847715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of heparin in women with early and late miscarriages with and without thrombophilia.
    Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
    Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
    Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials.
    Wang G; Zhang R; Li C; Chen A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7601-7608. PubMed ID: 34311655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
    Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
    Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
    Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism.
    Cetin O; Karaman E; Cim N; Dirik D; Sahin HG; Kara E; Esen R
    Ginekol Pol; 2017; 88(5):260-265. PubMed ID: 28580572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexplained recurrent miscarriages: Predictive value of immune biomarkers and immunomodulatory therapies for live birth.
    Carneiro C; Sarno M; Cavalcante M; Barini R
    Am J Reprod Immunol; 2022 Feb; 87(2):e13512. PubMed ID: 34921698
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial.
    Shaaban OM; Abbas AM; Zahran KM; Fathalla MM; Anan MA; Salman SA
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):567-572. PubMed ID: 27572887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
    Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I
    BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
    Dolitzky M; Inbal A; Segal Y; Weiss A; Brenner B; Carp H
    Fertil Steril; 2006 Aug; 86(2):362-6. PubMed ID: 16769056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine Radial Artery Resistance Index Predicts Reproductive Outcome in Women with Recurrent Pregnancy Losses and Thrombophilia.
    Bao SH; Chigirin N; Hoch V; Ahmed H; Frempong ST; Zhang M; Ruan JL; Kwak-Kim J
    Biomed Res Int; 2019; 2019():8787010. PubMed ID: 31534965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.